210 related articles for article (PubMed ID: 29562592)
21. New 5-Hydroxycoumarin-Based Tyrosyl-DNA Phosphodiesterase I Inhibitors Sensitize Tumor Cell Line to Topotecan.
Khomenko TM; Zakharenko AL; Kornienko TE; Chepanova AA; Dyrkheeva NS; Artemova AO; Korchagina DV; Achara C; Curtis A; Reynisson J; Volcho KP; Salakhutdinov NF; Lavrik OI
Int J Mol Sci; 2023 May; 24(11):. PubMed ID: 37298106
[TBL] [Abstract][Full Text] [Related]
22. New Hybrid Compounds Combining Fragments of Usnic Acid and Monoterpenoids for Effective Tyrosyl-DNA Phosphodiesterase 1 Inhibition.
Dyrkheeva NS; Filimonov AS; Luzina OA; Zakharenko AL; Ilina ES; Malakhova AA; Medvedev SP; Reynisson J; Volcho KP; Zakian SM; Salakhutdinov NF; Lavrik OI
Biomolecules; 2021 Jul; 11(7):. PubMed ID: 34356597
[TBL] [Abstract][Full Text] [Related]
23. Novel Inhibitors of DNA Repair Enzyme TDP1 Combining Monoterpenoid and Adamantane Fragments.
Mozhaitsev ES; Zakharenko AL; Suslov EV; Korchagina DV; Zakharova OD; Vasil'eva IA; Chepanova AA; Black E; Patel J; Chand R; Reynisson J; Leung IKH; Volcho KP; Salakhutdinov NF; Lavrik OI
Anticancer Agents Med Chem; 2019; 19(4):463-472. PubMed ID: 30523770
[TBL] [Abstract][Full Text] [Related]
24. Synthesis and Biological Activities of 11- and 12-Substituted Benzophenanthridinone Derivatives as DNA Topoisomerase IB and Tyrosyl-DNA Phosphodiesterase 1 Inhibitors.
Yang H; Qin C; Wu M; Wang FT; Wang W; Agama K; Pommier Y; Hu DX; An LK
ChemMedChem; 2023 May; 18(10):e202200593. PubMed ID: 36932053
[TBL] [Abstract][Full Text] [Related]
25. Tyrosyl-DNA phosphodiesterase as a target for anticancer therapy.
Dexheimer TS; Antony S; Marchand C; Pommier Y
Anticancer Agents Med Chem; 2008 May; 8(4):381-9. PubMed ID: 18473723
[TBL] [Abstract][Full Text] [Related]
26. Synthesis and biological evaluation of the first dual tyrosyl-DNA phosphodiesterase I (Tdp1)-topoisomerase I (Top1) inhibitors.
Nguyen TX; Morrell A; Conda-Sheridan M; Marchand C; Agama K; Bermingham A; Bermingam A; Stephen AG; Chergui A; Naumova A; Fisher R; O'Keefe BR; Pommier Y; Cushman M
J Med Chem; 2012 May; 55(9):4457-78. PubMed ID: 22536944
[TBL] [Abstract][Full Text] [Related]
27. Monoterpene substituted thiazolidin-4-ones as novel TDP1 inhibitors: Synthesis, biological evaluation and docking.
Ivankin DI; Dyrkheeva NS; Zakharenko AL; Ilina ES; Zarkov TO; Reynisson J; Luzina OA; Volcho KP; Salakhutdinov NF; Lavrik OI
Bioorg Med Chem Lett; 2022 Oct; 73():128909. PubMed ID: 35907608
[TBL] [Abstract][Full Text] [Related]
28. Inhibitory Effect of New Semisynthetic Usnic Acid Derivatives on Human Tyrosyl-DNA Phosphodiesterase 1.
Dyrkheeva N; Luzina O; Filimonov A; Zakharova O; Ilina E; Zakharenko A; Kuprushkin M; Nilov D; Gushchina I; Švedas V; Salakhutdinov N; Lavrik O
Planta Med; 2019 Jan; 85(2):103-111. PubMed ID: 30142660
[TBL] [Abstract][Full Text] [Related]
29. Tyrosyl-DNA Phosphodiesterase 1 Inhibitors: Usnic Acid Enamines Enhance the Cytotoxic Effect of Camptothecin.
Zakharenko A; Luzina O; Koval O; Nilov D; Gushchina I; Dyrkheeva N; Švedas V; Salakhutdinov N; Lavrik O
J Nat Prod; 2016 Nov; 79(11):2961-2967. PubMed ID: 27933897
[TBL] [Abstract][Full Text] [Related]
30. Inhibitors of human tyrosyl-DNA phospodiesterase (hTdp1) developed by virtual screening using ligand-based pharmacophores.
Weidlich IE; Dexheimer T; Marchand C; Antony S; Pommier Y; Nicklaus MC
Bioorg Med Chem; 2010 Jan; 18(1):182-9. PubMed ID: 19963390
[TBL] [Abstract][Full Text] [Related]
31. Novel group of tyrosyl-DNA-phosphodiesterase 1 inhibitors based on disaccharide nucleosides as drug prototypes for anti-cancer therapy.
Komarova AO; Drenichev MS; Dyrkheeva NS; Kulikova IV; Oslovsky VE; Zakharova OD; Zakharenko AL; Mikhailov SN; Lavrik OI
J Enzyme Inhib Med Chem; 2018 Dec; 33(1):1415-1429. PubMed ID: 30191738
[TBL] [Abstract][Full Text] [Related]
32. Deoxycholic acid as a molecular scaffold for tyrosyl-DNA phosphodiesterase 1 inhibition: A synthesis, structure-activity relationship and molecular modeling study.
Salomatina OV; Popadyuk II; Zakharenko AL; Zakharova OD; Chepanova AA; Dyrkheeva NS; Komarova NI; Reynisson J; Anarbaev RO; Salakhutdinov NF; Lavrik OI; Volcho KP
Steroids; 2021 Jan; 165():108771. PubMed ID: 33221302
[TBL] [Abstract][Full Text] [Related]
33. A Dual-Sensor-Based Screening System for In Vitro Selection of TDP1 Inhibitors.
Jakobsen AK; Keller JG; Gonzalez M; Martin-Encinas E; Palacios F; Alonso C; Knudsen BR; Stougaard M
Sensors (Basel); 2021 Jul; 21(14):. PubMed ID: 34300575
[TBL] [Abstract][Full Text] [Related]
34. Identification of phosphotyrosine mimetic inhibitors of human tyrosyl-DNA phosphodiesterase I by a novel AlphaScreen high-throughput assay.
Marchand C; Lea WA; Jadhav A; Dexheimer TS; Austin CP; Inglese J; Pommier Y; Simeonov A
Mol Cancer Ther; 2009 Jan; 8(1):240-8. PubMed ID: 19139134
[TBL] [Abstract][Full Text] [Related]
35. New Hydrazinothiazole Derivatives of Usnic Acid as Potent Tdp1 Inhibitors.
Filimonov AS; Chepanova AA; Luzina OA; Zakharenko AL; Zakharova OD; Ilina ES; Dyrkheeva NS; Kuprushkin MS; Kolotaev AV; Khachatryan DS; Patel J; Leung IKH; Chand R; Ayine-Tora DM; Reynisson J; Volcho KP; Salakhutdinov NF; Lavrik OI
Molecules; 2019 Oct; 24(20):. PubMed ID: 31619021
[TBL] [Abstract][Full Text] [Related]
36. Design, synthesis, and biological evaluation of O-2-modified indenoisoquinolines as dual topoisomerase I-tyrosyl-DNA phosphodiesterase I inhibitors.
Lv PC; Agama K; Marchand C; Pommier Y; Cushman M
J Med Chem; 2014 May; 57(10):4324-36. PubMed ID: 24800942
[TBL] [Abstract][Full Text] [Related]
37. Synthesis of 11-aminoalkoxy substituted benzophenanthridine derivatives as tyrosyl-DNA phosphodiesterase 1 inhibitors and their anticancer activity.
Yang H; Wang FT; Wu M; Wang W; Agama K; Pommier Y; An LK
Bioorg Chem; 2022 Jun; 123():105789. PubMed ID: 35429714
[TBL] [Abstract][Full Text] [Related]
38. Identification of a ligand binding hot spot and structural motifs replicating aspects of tyrosyl-DNA phosphodiesterase I (TDP1) phosphoryl recognition by crystallographic fragment cocktail screening.
Lountos GT; Zhao XZ; Kiselev E; Tropea JE; Needle D; Pommier Y; Burke TR; Waugh DS
Nucleic Acids Res; 2019 Nov; 47(19):10134-10150. PubMed ID: 31199869
[TBL] [Abstract][Full Text] [Related]
39. [Tyrosyl-DNA phosphodiesterases: potential targets for cancer treatment].
Hu Z; Wang HW; An LK
Yao Xue Xue Bao; 2016 Feb; 51(2):215-25. PubMed ID: 29856574
[TBL] [Abstract][Full Text] [Related]
40. Insights into substrate binding and catalytic mechanism of human tyrosyl-DNA phosphodiesterase (Tdp1) from vanadate and tungstate-inhibited structures.
Davies DR; Interthal H; Champoux JJ; Hol WG
J Mol Biol; 2002 Dec; 324(5):917-32. PubMed ID: 12470949
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
